Ann: Updated Shareholder / Investor Presentation, page-140

From the quarterly report!

Alexium continued robust growth during the period, with highlights being:

Cash Receipts of A$6.6M for the period, a 25% increase over the previous period and a 73% increase in cash receipts over the last two periods. With this period cash receipts, the six-month total of A $11.9M ending 03-31-2016 represents a 153% increase in cash receipts over the previous six-month period ending 9-30-2016 (A$4.7). Year to date cash receipts have increased 682% over the same period in the prior year.

Revenue From Chemistry Sales for the period grew 425% over the same period in the prior year on as a result of increased core chemistry sales across several markets and customers.

Average Monthly Recurring Revenue now exceeding A$2.0M per month following a rapid increase in sales of Alexicool into the bedding market.

Average Gross Margins well on track to exceed 40% in 2017 with Gross Margins in key markets on track to exceed 60% in 2017.

Cash Neutral Position remains expected for 2Q calendar 2017


What a remarkable effort only 3 quarters into making decent revenue, good times ahead!

Cheers